Liso-Cel a Potential New CAR-T Option for High-Risk R/R Foll

Study results show impressive efficacy, favorable safety profile in the second line

Related Keywords

United States , Greg Laub , Kami Maddocks , David Bond , Yazeed Sawalha , Ohio State University Wexner Medical Center , Transcend , American Society Of Hematology , American Society , Medpage Today , Senior Director ,